CKDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease

Repositioning Candidates

Repositioning candidates for CKD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and CKD-associated disease in CKDdb are presented with knowledge graphs.

stats1

stats2

stats3

Search for:

Insulin resistance

4 records.

Candidate ID	Source ID	Source Type	Compound Type	Candidate Name
R0048	DB00193	approved; investigational	small molecule	Tramadol	Details
R0135	DB00480	approved	small molecule	Lenalidomide	Details
R0150	DB00528	approved; investigational	small molecule	Lercanidipine	Details
R0160	DB00571	approved; investigational	small molecule	Propranolol	Details